Form 8-K - Current report:
SEC Accession No. 0000882095-20-000003
Filing Date
2020-02-04
Accepted
2020-02-04 16:06:18
Documents
16
Period of Report
2020-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8-kq419earningspre.htm   iXBRL 8-K 52125
2 EXHIBIT 99.1 exhibit991earningspres.htm EX-99.1 965232
8 GRAPHIC image0a09.jpg GRAPHIC 43356
  Complete submission text file 0000882095-20-000003.txt   1263080

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20200204.xsd EX-101.SCH 4563
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20200204_cal.xml EX-101.CAL 604
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20200204_def.xml EX-101.DEF 1454
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20200204_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20200204_pre.xml EX-101.PRE 13560
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-kq419earningspre_htm.xml XML 4261
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 20573714
SIC: 2836 Biological Products, (No Diagnostic Substances)